$IDEXQ
IDEANOMICS, INC. Stock $idexq

$idexq Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000110465921068054 Filed on May 17, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$32.71M	$378.0K
YoY Change	8553.17%	-98.59%
Cost Of Revenue	$21.87M	$334.0K
YoY Change	6447.01%	11.33%
Gross Profit	$10.84M	$44.00K
YoY Change	24540.91%	-99.84%
Gross Profit Margin	33.15%	11.64%
Selling, General & Admin	$12.01M	$5.827M
YoY Change	106.02%	5.95%
% of Gross Profit	110.73%	13243.18%
Research & Development	$10.00K	$0.00
YoY Change
% of Gross Profit	0.09%	0.0%
Depreciation & Amortization	$1.130M	$480.0K
YoY Change	135.42%	100.0%
% of Gross Profit	10.42%	1090.91%
Operating Expenses	$23.81M	$9.479M
YoY Change	151.13%	66.3%
Operating Profit	-$12.96M	-$9.435M
YoY Change	37.39%	-144.93%
Interest Expense	$417.0K	$3.156M
YoY Change	-86.79%	-415.6%
% of Operating Profit
Other Income/Expense, Net	-$2.000K	-$26.00K
YoY Change	-92.31%	-74.0%
Pretax Income	-$13.65M	-$12.62M
YoY Change	8.19%	-163.74%
Income Tax	-$12.90M	$0.00
% Of Pretax Income
Net Earnings	-$573.0K	-$12.35M
YoY Change	-95.36%	-162.02%
Net Earnings / Revenue	-1.75%	-3266.67%
Basic Earnings Per Share	$0.00	-$0.08
Diluted Earnings Per Share	$0.00	-$0.08
COMMON SHARES
Basic Shares Outstanding	391.1M	157.9M
Diluted Shares Outstanding	391.1M	157.9M

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$371.0M	$5.900M
YoY Change	6188.14%	195.0%
Cash & Equivalents	$355.9M	$5.900M
Short-Term Investments	$15.20M
Other Short-Term Assets	$479.0K	$1.100M
YoY Change	-56.45%	-82.81%
Inventory	$960.0K
Prepaid Expenses	$6.400M
Receivables	$5.409M	$1.800M
Other Receivables	$300.0K	$1.300M
Total Short-Term Assets	$391.6M	$10.10M
YoY Change	3776.95%	-63.67%
LONG-TERM ASSETS
Property, Plant & Equipment	$631.0K	$19.00M
YoY Change	-96.68%	-15.18%
Goodwill	$51.08M
YoY Change
Intangibles	$92.53M
YoY Change
Long-Term Investments	$16.02M	$22.60M
YoY Change	-29.11%	-1.31%
Other Assets	$569.0K	$900.0K
YoY Change	-36.78%	-77.5%
Total Long-Term Assets	$178.3M	$104.8M
YoY Change	70.16%	-11.49%
TOTAL ASSETS
Total Short-Term Assets	$391.6M	$10.10M
Total Long-Term Assets	$178.3M	$104.8M
Total Assets	$569.9M	$114.9M
YoY Change	395.99%	-21.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.978M	$3.700M
YoY Change	169.68%	-80.73%
Accrued Expenses	$5.800M	$2.200M
YoY Change	163.64%
Deferred Revenue
YoY Change
Short-Term Debt	$900.0K	$3.000M
YoY Change	-70.0%
Long-Term Debt Due	$80.40M	$7.600M
YoY Change	957.89%	76.74%
Total Short-Term Liabilities	$120.8M	$30.80M
YoY Change	292.16%	-31.25%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$8.400M
YoY Change	-100.0%	-30.0%
Other Long-Term Liabilities	$1.175M	$21.80M
YoY Change	-94.61%	45.33%
Total Long-Term Liabilities	$1.175M	$30.20M
YoY Change	-96.11%	11.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$120.8M	$30.80M
Total Long-Term Liabilities	$1.175M	$30.20M
Total Liabilities	$140.4M	$81.70M
YoY Change	71.81%	14.75%
SHAREHOLDERS EQUITY
Retained Earnings	-$347.5M
YoY Change
Common Stock	$419.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$414.9M	$33.30M
YoY Change
Total Liabilities & Shareholders Equity	$569.9M	$114.9M
YoY Change	395.99%	-21.41%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	-$573.0K	-$12.35M
YoY Change	-95.36%	-162.02%
Depreciation, Depletion And Amortization	$1.130M	$480.0K
YoY Change	135.42%	100.0%
Cash From Operating Activities	$2.571M	-$3.858M
YoY Change	-166.64%	-19.12%
INVESTING ACTIVITIES
Capital Expenditures	$157.0K	$15.00K
YoY Change	946.67%	-102.59%
Acquisitions
YoY Change
Other Investing Activities	-$85.97M	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$86.13M	-$15.00K
YoY Change	574093.33%	-98.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$53.40M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	273.7M	7.148M
YoY Change	3728.47%	47.08%
NET CHANGE
Cash From Operating Activities	2.571M	-3.858M
Cash From Investing Activities	-86.13M	-15.00K
Cash From Financing Activities	273.7M	7.148M
Net Change In Cash	190.1M	3.281M
YoY Change	5693.72%	-395.59%
FREE CASH FLOW
Cash From Operating Activities	$2.571M	-$3.858M
Capital Expenditures	$157.0K	$15.00K
Free Cash Flow	$2.414M	-$3.873M
YoY Change	-162.33%	-7.57%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000837852
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0Y
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	419469800
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	344906295
CY2021Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	7000000
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	7000000
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	761155000
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	531866000
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-347457000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-346883000
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	784000
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1256000
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1128000
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	476000
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	001-35561
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	IDEANOMICS, INC.
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-1778374
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1441 Broadway, Suite 5116
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10018
CY2021Q1	dei	City Area Code CityAreaCode	212
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	206-1216
CY2021Q1	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value per share
CY2021Q1	dei	Trading Symbol TradingSymbol	IDEX
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	425900124
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	355856000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	165764000
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5409000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7400000
CY2021Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	15155000
CY2020Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	0
CY2021Q1	us-gaap	Inventory Net InventoryNet	960000
CY2020Q4	us-gaap	Inventory Net InventoryNet	0
CY2021Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6400000
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2629000
CY2021Q1	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	245000
CY2020Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	240000
CY2021Q1	us-gaap	Other Assets Current OtherAssetsCurrent	479000
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3726000
CY2021Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	7068000
CY2020Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0
CY2021Q1	us-gaap	Assets Current AssetsCurrent	391572000
CY2020Q4	us-gaap	Assets Current AssetsCurrent	179759000
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	631000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	330000
CY2021Q1	idex	Fintech Village Non Core Asset Noncurrent FintechVillageNonCoreAssetNoncurrent	0
CY2020Q4	idex	Fintech Village Non Core Asset Noncurrent FintechVillageNonCoreAssetNoncurrent	7250000
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	92525000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	29705000
CY2021Q1	us-gaap	Goodwill Goodwill	51084000
CY2020Q4	us-gaap	Goodwill Goodwill	1165000
CY2020Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	7000000
CY2021Q1	us-gaap	Long Term Investments LongTermInvestments	24179000
CY2020Q4	us-gaap	Long Term Investments LongTermInvestments	8570000
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9338000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7117000
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	569000
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	516000
CY2021Q1	us-gaap	Assets Assets	569898000
CY2020Q4	us-gaap	Assets Assets	234412000
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	9978000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5057000
CY2021Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2225000
CY2020Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1129000
CY2021Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	4831000
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1750000
CY2021Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1235000
CY2020Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	882000
CY2021Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7112000
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1920000
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	955000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	430000
CY2021Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	8481000
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1325000
CY2021Q1	idex	Promissory Notes Current PromissoryNotesCurrent	869000
CY2020Q4	idex	Promissory Notes Current PromissoryNotesCurrent	568000
CY2021Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	80446000
CY2020Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0
CY2021Q1	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	4653000
CY2020Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	0
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	120785000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13061000
CY2021Q1	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	0
CY2020Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	4653000
CY2021Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1290000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8485000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6759000
CY2021Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	8630000
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	7635000
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1175000
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	535000
CY2021Q1	us-gaap	Liabilities Liabilities	140365000
CY2020Q4	us-gaap	Liabilities Liabilities	32643000
CY2021Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	7000000
CY2021Q1	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	3500000
CY2020Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	3500000
CY2021Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	1262000
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	1262000
CY2021Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	7600000
CY2021Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	1000
CY2020Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	0
CY2020Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	7485000
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	419469800
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	344906295
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	419000
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	345000
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2000
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-26000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	414901000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	186584000
CY2021Q1	us-gaap	Minority Interest MinorityInterest	5770000
CY2020Q4	us-gaap	Minority Interest MinorityInterest	6438000
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	420671000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	193022000
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	569898000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	234412000
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32709000
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	378000
CY2021Q1	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	7000
CY2020Q1	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	0
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	21867000
CY2020Q1	us-gaap	Cost Of Revenue CostOfRevenue	334000
CY2021Q1	us-gaap	Gross Profit GrossProfit	10842000
CY2020Q1	us-gaap	Gross Profit GrossProfit	44000
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12005000
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5827000
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10000
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0
CY2021Q1	us-gaap	Professional Fees ProfessionalFees	5168000
CY2020Q1	us-gaap	Professional Fees ProfessionalFees	1757000
CY2021Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2020Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	887000
CY2021Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	494000
CY2020Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	532000
CY2021Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	5000000
CY2020Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1128000
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	476000
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	23805000
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	9479000
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12963000
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9435000
CY2021Q1	us-gaap	Interest Expense InterestExpense	417000
CY2020Q1	us-gaap	Interest Expense InterestExpense	3156000
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-59000
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3000
CY2021Q1	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	-212000
CY2020Q1	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	0
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13653000
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12620000
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-12916000
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-737000
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-12620000
CY2021Q1	idex	Net Income Losses Attributable To Noncontrolling Interest NetIncomeLossesAttributableToNoncontrollingInterest	-164000
CY2021Q1	idex	Asset Impairment Charge AssetImpairmentCharge	0
CY2021Q1	idex	Stock Issued During Period Value Acquisitions Of Ya Ii StockIssuedDuringPeriodValueAcquisitionsOfYaIi	140126000
CY2021Q1	idex	Non Cash Interest Expense NonCashInterestExpense	417000
CY2020Q1	idex	Non Cash Interest Expense NonCashInterestExpense	3156000
CY2020Q1	idex	Net Income Losses Attributable To Noncontrolling Interest NetIncomeLossesAttributableToNoncontrollingInterest	-272000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-573000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-12348000
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	391131793
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	157859642
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	391131793
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	157859642
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-737000
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-12620000
CY2020Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0
CY2021Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-860000
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	7000
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1597000
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-12613000
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	552000
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-249000
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1045000
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12862000
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	58737000
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2202000
CY2020Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	240000
CY2020Q1	idex	Stock Issued During Period Value Acquisitions Of Ya Ii StockIssuedDuringPeriodValueAcquisitionsOfYaIi	614000
CY2020Q1	idex	Stock Issued During Period Value Acquisitions Of Dbot StockIssuedDuringPeriodValueAcquisitionsOfDbot	6748000
CY2020Q1	idex	Stock Issued During Period Value Issued For Warrants Exercised StockIssuedDuringPeriodValueIssuedForWarrantsExercised	1000000
CY2020Q1	idex	Non Controlling Interest Measurement Period Adjustment NonControllingInterestMeasurementPeriodAdjustment	-11454000
CY2020Q1	idex	Non Controlling Shareholder Contribution NonControllingShareholderContribution	100000
CY2020Q1	idex	Profit Loss Including Portion Attributable To Noncontrolling Interest ProfitLossIncludingPortionAttributableToNoncontrollingInterest	-12726000
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	7000
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	45468000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	193022000
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2040000
CY2021Q1	idex	Stock Issued During Period Value Acquisitions Of Dbot StockIssuedDuringPeriodValueAcquisitionsOfDbot	32377000
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1162000
CY2021Q1	idex	Common Stock Issued Value Under Employee Stock Incentive Plan CommonStockIssuedValueUnderEmployeeStockIncentivePlan	251000
CY2021Q1	idex	Stock Issued During Period Value Acquisitions1 StockIssuedDuringPeriodValueAcquisitions1	53407000
CY2021Q1	idex	Profit Loss Including Portion Attributable To Noncontrolling Interest ProfitLossIncludingPortionAttributableToNoncontrollingInterest	-854000
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-860000
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	420671000
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-737000
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-12620000
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2040000
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2202000
CY2020Q1	idex	Asset Impairment Charge AssetImpairmentCharge	887000
CY2021Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	5000000
CY2020Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0
CY2021Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	494000
CY2021Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0
CY2021Q1	idex	Income Tax Expense Benefits IncomeTaxExpenseBenefits	-13281000
CY2020Q1	idex	Income Tax Expense Benefits IncomeTaxExpenseBenefits	0
CY2021Q1	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	-212000
CY2020Q1	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	0
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-59000
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3000
CY2020Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	532000
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2600000
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-571000
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-117000
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1653000
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1928000
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	2438000
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	275000
CY2021Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-613000
CY2020Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	23000
CY2021Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	348000
CY2020Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	856000
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	696000
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2147000
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2571000
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3858000
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	157000
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15000
CY2021Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	55265000
CY2020Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	0
CY2021Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	15707000
CY2020Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0
CY2021Q1	idex	Payments To Acquire Invetment In Securities PaymentsToAcquireInvetmentInSecurities	15000000
CY2020Q1	idex	Payments To Acquire Invetment In Securities PaymentsToAcquireInvetmentInSecurities	0
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-86129000
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15000
CY2021Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	220000000
CY2020Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	2000000
CY2021Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	53659000
CY2020Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1000000
CY2021Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0
CY2020Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	7147000
CY2020Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-2999000
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	273659000
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7148000
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-9000
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	6000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	190092000
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3281000
CY2020Q4	us-gaap	Cash Cash	165764000
CY2019Q4	us-gaap	Cash Cash	2633000
CY2021Q1	us-gaap	Cash Cash	355856000
CY2020Q1	us-gaap	Cash Cash	5914000
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	0
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	0
CY2021Q1	us-gaap	Stock Issued1 StockIssued1	0
CY2020Q1	us-gaap	Stock Issued1 StockIssued1	6748000
CY2021Q1	idex	Purchase Price Adjustment In Acquisitions PurchasePriceAdjustmentInAcquisitions	0
CY2020Q1	idex	Purchase Price Adjustment In Acquisitions PurchasePriceAdjustmentInAcquisitions	11895000
CY2021Q1	idex	Stockissuedduringperiodvalueacquisitionoflongterminvestments Stockissuedduringperiodvalueacquisitionoflongterminvestments	32377000
CY2020Q1	idex	Stockissuedduringperiodvalueacquisitionoflongterminvestments Stockissuedduringperiodvalueacquisitionoflongterminvestments	0
CY2021Q1	idex	Stock Issued During Period Value Acquisitions Of Convertible Note Conversion StockIssuedDuringPeriodValueAcquisitionsOfConvertibleNoteConversion	140126000
CY2020Q1	idex	Stock Issued During Period Value Acquisitions Of Convertible Note Conversion StockIssuedDuringPeriodValueAcquisitionsOfConvertibleNoteConversion	0
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as well as the related disclosure of contingent assets and liabilities. Actual results could differ from those estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">On an ongoing basis, management evaluates the Company’s estimates, including those related to the bad debt allowance, variable considerations, fair values of financial instruments, intangible assets (including digital currencies) and goodwill, useful lives of intangible assets and property and equipment, asset retirement obligations, income taxes, and contingent liabilities, among others. The Company bases its estimates on assumptions, both historical and forward looking, that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</p>
CY2021Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	300000
CY2021Q1	us-gaap	Escrow Deposit EscrowDeposit	77800000
CY2021Q1	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	600000
CY2021Q2	idex	Number Of Cases In Covid19 Virus NumberOfCasesInCovid19Virus	156400000
CY2021Q2	idex	Number Of Deaths Cases In Covid19 Virus NumberOfDeathsCasesInCovid19Virus	3300000
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32709000
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	378000
CY2021Q1	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	300000
CY2021Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	34149000
CY2020Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	15216000
CY2021Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-242000
CY2020Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-12058000
CY2021Q1	idex	Business Acquisition Pro Forma Earnings Per Share Basic And Diluted BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted	0.00
CY2020Q1	idex	Business Acquisition Pro Forma Earnings Per Share Basic And Diluted BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted	-0.07
CY2021Q1	idex	Business Acquisition Pro Forma Weighted Average Shares Outstanding Basic And Diluted BusinessAcquisitionProFormaWeightedAverageSharesOutstandingBasicAndDiluted	393191290
CY2020Q1	idex	Business Acquisition Pro Forma Weighted Average Shares Outstanding Basic And Diluted BusinessAcquisitionProFormaWeightedAverageSharesOutstandingBasicAndDiluted	170448990
CY2021Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	6625000
CY2020Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	8619000
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1216000
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1219000
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5409000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7400000
CY2021Q1	idex	Taxi Commission Revenue Receivables TaxiCommissionRevenueReceivables	1200000
CY2020	idex	Taxi Commission Revenue Receivables TaxiCommissionRevenueReceivables	1200000
CY2021Q1	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	0
CY2021Q1	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	0
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	3000
CY2020Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	4653000
CY2021Q1	us-gaap	Asset Retirement Obligation Liabilities Incurred AssetRetirementObligationLiabilitiesIncurred	0
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1219000
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-1219000
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1216000
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1219000
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1154000
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	790000
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	523000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	460000
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	631000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	330000
CY2021Q1	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	0
CY2021Q1	us-gaap	Asset Retirement Obligation AssetRetirementObligation	4653000
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	2556000
CY2021Q1	us-gaap	Long Term Investments LongTermInvestments	24179000
CY2019Q4	us-gaap	Goodwill Goodwill	23344000
CY2020	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-12848000
CY2020	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-8000
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	9323000
CY2020Q4	us-gaap	Goodwill Goodwill	1165000
CY2021Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	49933000
CY2021Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-14000
CY2021Q1	us-gaap	Goodwill Goodwill	51084000
CY2021Q1	idex	Indefinite Lived Intangible Assets Excluding Good Will Gross IndefiniteLivedIntangibleAssetsExcludingGoodWillGross	94729000
CY2021Q1	idex	Indefinite Lived Intangible Assets Accumulated Amortization IndefiniteLivedIntangibleAssetsAccumulatedAmortization	-2757000
CY2021Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	91972000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	31378000
CY2020Q4	idex	Indefinite Lived Intangible Assets Accumulated Amortization IndefiniteLivedIntangibleAssetsAccumulatedAmortization	-1726000
CY2020Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	29652000
CY2021Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	95282000
CY2021Q1	idex	Intangible Assets Accumulated Amortization IntangibleAssetsAccumulatedAmortization	2757000
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	92525000
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	31431000
CY2020Q4	idex	Intangible Assets Accumulated Amortization IntangibleAssetsAccumulatedAmortization	1726000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	29705000
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1000000.0
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	400000
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	3755000
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	4722000
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4384000
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4384000
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4384000
CY2021Q1	idex	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	70343000
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	91972000
CY2020Q4	us-gaap	Long Term Investments LongTermInvestments	8570000
CY2021Q1	idex	Non Marketable Equity Investment NonMarketableEquityInvestment	8158000
CY2020Q4	idex	Non Marketable Equity Investment NonMarketableEquityInvestment	6014000
CY2021Q1	us-gaap	Equity Method Investments EquityMethodInvestments	16021000
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	2556000
CY2021Q1	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	13555000
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-59000
CY2021Q1	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0
CY2021Q1	us-gaap	Equity Method Investment Sold Carrying Amount EquityMethodInvestmentSoldCarryingAmount	0
CY2021Q1	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-31000
CY2021Q1	us-gaap	Equity Method Investments EquityMethodInvestments	16021000
CY2020Q4	idex	Consideration Per Share ConsiderationPerShare	1.00
CY2020Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	1300000
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9300000
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	9400000
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P11Y3M18D
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.042
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	338000
CY2020Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	487000
CY2021Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	88000
CY2020Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	85000
CY2020Q1	us-gaap	Sublease Income SubleaseIncome	32000
CY2021Q1	us-gaap	Lease Cost LeaseCost	426000
CY2020Q1	us-gaap	Lease Cost LeaseCost	540000
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	319000
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	553000
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1671000
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	322000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1064000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1262000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1207000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	897000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	835000
CY2020Q4	idex	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	6771000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	12036000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2596000
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9440000
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0
CY2021Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	80865000
CY2021Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	81315000
CY2020Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	565000
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	568000
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	0
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	0
CY2021Q1	idex	Aggregate Offering Price AggregateOfferingPrice	150000000.0
CY2021Q1	idex	Common Stock Share Price Calculated As Percentage Of Market Price CommonStockSharePriceCalculatedAsPercentageOfMarketPrice	0.030
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	53400000
CY2021Q1	idex	Commission And Transaction Fees CommissionAndTransactionFees	1700000
CY2020Q2	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	100000
CY2021Q1	us-gaap	Due To Other Related Parties Classified Current DueToOtherRelatedPartiesClassifiedCurrent	100000
CY2021Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1100000
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2000000.0
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2200000
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	8000000.0
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y2M26D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	500000
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1900000
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2200000
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	45052000
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	28018000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0
CY2021Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.00
CY2021Q1	idex	Weighted Average Remaining Life Of Warrants WeightedAverageRemainingLifeOfWarrants	P1Y4M9D
CY2021Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1100000
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	900000
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-573000
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12348000
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	391131793
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	157859642
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	391131793
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	157859642
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-12900000
CY2021Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0
CY2021Q1	idex	Valuation Allowance Percentage ValuationAllowancePercentage	1
CY2020Q1	idex	Valuation Allowance Percentage ValuationAllowancePercentage	1
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q2	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	5000000

Files In Submission

Name	View Source	Status
0001104659-21-068054-index-headers.html	Edgar Link	pending
0001104659-21-068054-index.html	Edgar Link	pending
0001104659-21-068054.txt	Edgar Link	pending
0001104659-21-068054-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
idex-20210331.xsd	Edgar Link	pending
idex-20210331x10q.htm	Edgar Link	pending
idex-20210331x10q_htm.xml	Edgar Link	completed
idex-20210331xex10d1.htm	Edgar Link	pending
idex-20210331xex31d1.htm	Edgar Link	pending
idex-20210331xex31d2.htm	Edgar Link	pending
idex-20210331xex32d1.htm	Edgar Link	pending
idex-20210331xex32d2.htm	Edgar Link	pending
idex-20210331_cal.xml	Edgar Link	unprocessable
idex-20210331_def.xml	Edgar Link	unprocessable
idex-20210331_lab.xml	Edgar Link	unprocessable
idex-20210331_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IDEXQ
IDEANOMICS, INC. Stock $idexq

2021 Q1 Form 10-Q Financial Statement

#000110465921068054 Filed on May 17, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IDEXQ IDEANOMICS, INC. Stock $idexq

2021 Q1 Form 10-Q Financial Statement

#000110465921068054 Filed on May 17, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IDEXQ
IDEANOMICS, INC. Stock $idexq